Today, at the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (Virtual WCO-IOF-ESCEO 2021), Dr Ngozi Rosemary Njeze was awarded the IOF Committee of National Societies (CNS) Medal. The CNS Medal recognizes an individual who has made an important contribution to the cause of osteoporosis prevention through active participation in CNS activities and by expanding IOF’s messages and outreach in his/her country. 

The CNS, comprising 268 patient and medical societies in more than 100 countries, is IOF’s core membership committee. It represents the world’s largest single network of global, regional and national organizations dedicated to bone health and the prevention of osteoporosis and fragility fractures.

Professor Jean-Yves Reginster, Chair of the CNS and IOF Board member, presented the CNS Medal and stated: 

“As the founder and Chair of the Foundation for Awareness of Osteoporosis in Nigeria, Dr Ngozi Rosemary Njeze has shown exemplary dedication to raising awareness of bone health and osteoporosis prevention in Africa’s most populous country. We also recognize Dr Njeze’s ongoing support of IOF initiatives, including her participation at a recent IOF webinar on fragility fractures in Sub-Saharan Africa. The demographic shift in population ageing now seen in the region has enormous implications for musculoskeletal health, and gives new urgency to the need for greater bone health awareness and education among the public, health professionals and policymakers.”

Dr Ngozi Rosemary Njeze is a Senior Lecturer at the Enugu Campus of the University of Nigeria and a Consultant Radiologist at the University of Nigeria Teaching Hospital, Ituku Ozalla, Enugu. She is a Fellow and an Examiner of the National Postgraduate Medical College of Nigeria and also participates in several of the University’s committees such as the University of Nigeria Examiners’ Board and the University Games Local Organizing Committee. Dr Njeze’s mentorship and training of medical students and resident doctors reflects her keen interest in students’ welfare and human development and she continues to inspire members of the University of Nigeria Medical School with vision and direction (one of her mentees went on to win the young investigator’s award at the 2020 WCO-IOF-ESCEO annual Congress). She is also the author of a handbook entitled “Osteoporosis - A Friend or a Silent Killer” to further spread knowledge and awareness of Osteoporosis in her country.

Dr Njeze is the founder and Chair of the Foundation for Awareness of Osteoporosis, and the society’s representative for the IOF. The society organises workshops on osteoporosis, as well as radio and television talks on osteoporosis to reach out to new audiences , to provide education and raise awareness of bone health and osteoporosis.

###

About the World Congress on Osteoporosis, Osteoarthritis & Musculoskeletal Diseases (WCO-IOF-ESCEO)
Held jointly by IOF and ESCEO, the WCO-IOF-ESCEO annual congress is the world’s largest forum for the presentation of clinical research and new advances in the prevention and management of musculoskeletal disorders, including sarcopenia and frailty. WCO-IOF-ESCEO 2021 is being held as a virtual congress from August 26 to 28, 2021, with registrants having access on demand to the full program for three months following the congress. 
For complete information visit http://virtual.wco-iof-esceo.org/   #OsteoCongress

About IOF
The International Osteoporosis Foundation (IOF) is the world's largest nongovernmental organization dedicated to the prevention, diagnosis and treatment of osteoporosis and related musculoskeletal diseases. IOF members, including committees of scientific researchers as well as 268 patient, medical and research societies, work together to make fracture prevention and healthy mobility a worldwide heath care priority. https://www.osteoporosis.foundation  @iofbonehealth

About ESCEO
The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) is a non-profit organization, dedicated to a close interaction between clinical scientists dealing with rheumatic disorders, pharmaceutical industry developing new compounds in this field, regulators responsible for the registration of such drugs and health policy makers, to integrate the management of osteoporosis and osteoarthritis within the comprehensive perspective of health resources utilization. The objective of ESCEO is to provide practitioners with the latest clinical and economic information, allowing them to organize their daily practice, in an evidence-based medicine perspective, with a cost-conscious perception. www.esceo.org